Lumos Diagnostics Holdings Ltd. has released a press release.
FebriDx Commercial Traction Across Priority US Accounts
Earlier from Lumos Diagnostics
- FebriDx U.S. Rollout and Reimbursement Update - Amended
- FebriDx U.S. Rollout and Reimbursement Update
- FebriDx Paediatric Study Enrolment Milestone Achieved
- Response to ASX Aware Letter

